GLAM
BOLD

Gardner Lewis Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Gardner Lewis Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-647,460
Closed -$38.7M – 97
2019
Q4 		$38.7M Buy
+647,460
New +$24.3M 5.28% 5

Gardner Lewis Asset Management's BOLD Position: Q1 2020 in Review

Gardner Lewis Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 647,460 shares — an estimated $38.7M sold.

Gardner Lewis Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $38.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Gardner Lewis Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 647,460 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $38.7M.
  • Gardner Lewis Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Audentes Therapeutics, Inc position peaked at $38.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2020, filed 15 May 2020.